Serotype distribution, antimicrobial resistance, and molecular characterization of group B Streptococcus isolates from Chinese pregnant woman

• Published in: The journal of maternal-fetal & neonatal medicine Vol. 37; no. 1; p. 2295805
• Main Authors: Chen, Yifei, Liu, Lin, Liu, Jing, Ji, Tongzhen, Gao, Yang, Yang, Dongmei, Zhao, Mohan, Zhai, Yanhong, Cao, Zheng
• Format: Journal Article
• Language: English
• Published: England 01.12.2024
• Subjects: Anti-Bacterial Agents - pharmacology; Anti-Bacterial Agents - therapeutic use; China - epidemiology; Clindamycin - pharmacology; Clindamycin - therapeutic use; Drug Resistance, Bacterial - genetics; Erythromycin - pharmacology; Female; Humans; Microbial Sensitivity Tests; Multilocus Sequence Typing; Pregnancy; Pregnant Women; Serogroup; Streptococcal Infections - drug therapy; Streptococcal Infections - epidemiology; Streptococcus agalactiae - genetics; China; serotyping; GBS; mLST; susceptibility; pregnancy
• ISSN: 1476-7058; 1476-4954
• DOI: 10.1080/14767058.2023.2295805

This study was aimed to investigate the serotypes, antibiotic susceptibilities, and multi-locus sequence type (MLST) profiles of group B (GBS) in the Beijing area. Lower vaginal and rectal swabs were obtained from pregnant women of 35-37 gestational weeks (GWs) who attended the Beijing Obstetrics and Gynecology Hospital. All GBS isolates were identified with Gram staining, catalase reaction assays, and CAMP tests, followed by antibiotic susceptibility testing, serotype identification, multilocus sequence typing and erythromycin resistance gene analysis ( and ). From July 2020 to June 2022, 311 (5.17%) of 6012 pregnant women that were screened for GBS colonization were detected positive. Of the eight serotypes identified (III, Ia, Ib, IV, II, VIII, V, and NT), serotypes III (43.09%), Ia (34.08%) and Ib (17.04%) were the predominant species. In the antimicrobial susceptibility experiments, the resistant rates measured for erythromycin, clindamycin, levofloxacin, and tetracycline were 76.21%, 63.99%, 50.80%, and 81.03%, respectively, and 7.6% of GBS isolates showed inducible clindamycin in resistance (D-test phenotype). Meanwhile, the multilocus sequence typing analysis showed that sequence type 19 (ST19) (30.34%) and ST10 (18.62%) were the dominant sequence types. Among the 237 erythromycin-resistant isolates, 176 harbored (128, 54.00%) or (48, 20.30%) gene alone. The infection rates, serotypes or MSLT distribution, and antimicrobial resistance of GBS in Beijing area were investigated, which may be applied in analyses of the epidemiological characteristics of GBS. This contributes to the basic knowledge required for successful GBS vaccine development suited for disease prevention and treatment in China, as well as the implementation of effective clinical antimicrobials.